IPO registrations (S-1, F-1) · Registrants
PRAECIS PHARMACEUTICALS INC
- SEC CIK
- 1033025 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1998-08-12, last 2001-02-14; 3 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2000-04-27; withdrawal requested 1999-04-08
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 830 WINTER STREET, Waltham, MA 02451
- EIN
- 04-3200305
- EDGAR entity type
- operating
- Insiders and CEO pay
- PRAECIS PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2000-04-26)
- Final price
- $10.00 per share, within the range (424B1 filed 2000-04-27, an initial public offering)
- Shares sold
- 8,000,000
- Gross proceeds
- $80,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PRCS
- Lead underwriters
- Citigroup (3,601,000 shares); CIBC World Markets (1,801,000 shares); Credit Suisse (1,801,000 shares)
- Syndicate
- ABN AMRO (80,000); Deutsche Bank (80,000); Prudential Securities (80,000); Piper Sandler (80,000); Fahnestock & Co. Inc (53,000); Gerard Klauer Mattison & Co., LLC (53,000); Leerink Partners (53,000); Legg Mason (53,000); Needham & Company (53,000); Parker/Hunter Incorporated (53,000); Truist Securities (53,000); Tucker Anthony Incorporated (53,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Lobbying client: PRAECIS PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: PRAECIS PHARMACEUTICALS INCORPORATED Fuzzy (name and state)
- SEC filer: PRAECIS PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Person page: Henry F McCance Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1998-08-12 | S-1 | S-1 (registration) | PRAECIS PHARMACEUTICALS INC | 0001047469-98-030519 ↗ |
| 1999-04-08 | RW | RW (withdrawal request) | PRAECIS PHARMACEUTICALS INC | 0000950172-99-000395 ↗ |
| 2000-02-08 | S-1 | S-1 (registration) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-004383 ↗ |
| 2000-03-10 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-010882 ↗ |
| 2000-03-28 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-014079 ↗ |
| 2000-03-31 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-015446 ↗ |
| 2000-04-03 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-015781 ↗ |
| 2000-04-20 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-019046 ↗ |
| 2000-04-26 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-019677 ↗ |
| 2000-04-27 | 424B1 | 424B1 (final prospectus) | PRAECIS PHARMACEUTICALS INC | 0000912057-00-019877 ↗ |
| 2001-01-26 | S-1 | S-1 (registration) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-002877 ↗ |
| 2001-01-31 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-003537 ↗ |
| 2001-02-12 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-004551 ↗ |
| 2001-02-14 | S-1/A | S-1/A (amendment) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-005321 ↗ |
| 2001-02-14 | S-1MEF | S-1MEF (added securities) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-005903 ↗ |
| 2001-02-15 | 424B4 | 424B4 (final prospectus) | PRAECIS PHARMACEUTICALS INC | 0000912057-01-005972 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-04-26 | S-1/A | registration statement | $10.00–$12.00 | 8,000,000 | - | Nasdaq PRCS | 3 | from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2000-04-27 | 424B1 | final prospectus | $10.00 | 8,000,000 | $80,000,000 | Nasdaq PRCS | 15 | from the submission text; price sentence, shares headline, proceeds table, underwriting table 15, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| GEFTER MALCOLM L PHD | Director; Director,Officer | Chairman and CSO | 3 | 2006–2007 | |
| GARNICK MARC B | Officer | EVP and Chief Medical Officer | 1 | 2006 | |
| MCLAUGHLIN KEVIN F | Director,Officer | President and CEO | 2 | 2006–2007 | |
| BAKER G LEONARD JR | Director | 1 | 2007 | ||
| BOHLIN GAREN G | Director | 1 | 2007 | ||
| English Edward C | Officer | VP, CFO, Treasurer & Ass. Sec. | 1 | 2007 | |
| MCCANCE HENRY F | Director | 1 | 2007 | person page Fuzzy | |
| POST LEONARD E | Director | 1 | 2007 | ||
| WAGNER RICHARD W | Officer | EVP, Discovery Research | 1 | 2007 | |
| ZENNER PATRICK J | Director | 1 | 2007 | ||
| SHARROCK DAVID B | Director | 1 | 2007 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Lobbying client | PRAECIS PHARMACEUTICALS | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | PRAECIS PHARMACEUTICALS INCORPORATED | MA | Federal lobbying (LDA) | name and state |
| Patent assignee | Praecis Pharmaceuticals, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | PRAECIS PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Henry F McCance | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MA first:
- ERGO SCIENCE CORP MA
- MILLENNIUM PHARMACEUTICALS INC MA
- ESSENTIAL THERAPEUTICS INC MA
- ARQULE INC MA
- ASCENT PEDIATRICS INC MA
- EPIX Pharmaceuticals, Inc. MA
- PARATEK PHARMACEUTICALS INC MA
- PREDIX PHARMACEUTICALS HOLDINGS INC MA
- CervoMed Inc. MA
- Euthymics Bioscience, Inc. MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health